Rossi Esther Diana, Faquin William C, Baloch Zubair, Barkan Güliz A, Foschini Maria Pia, Pusztaszeri Marc, Vielh Philippe, Kurtycz Daniel F I
Division of Anatomic Pathology and Histology, Agostino Gemelli School of Medicine, Catholic University of the Sacred Heart, Rome, Italy.
Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Cancer Cytopathol. 2017 Oct;125(10):757-766. doi: 10.1002/cncy.21898. Epub 2017 Jul 14.
An international panel of experts in the field of salivary gland cytology (SGC), supported by the American Society of Cytopathology (ASC) and the International Academy of Cytology, conducted a survey to seek evidence and practice patterns regarding SGC. Results were used to provide focus for the proposed Milan System for Reporting Salivary Gland Cytopathology.
The study group, formed during the 2015 European Congress of Cytology held in Milan, Italy, generated a survey that included 49 specific questions related to the taxonomies, practices, and diagnostic entities of salivary cytology. Qualtrics software was used as the study platform. Software and server support were provided by the division of information technology at the University of Wisconsin. The survey was available online from November 2015 until February 2016. Participants were invited through the Web sites of the ASC, the International Academy of Cytology, and the Papanicolaou Society of Cytopathology as well as by the ASC e-mail "ListServe"; responses were evaluated by the Milan System editors.
Responses from a total of 515 participants were collected and reviewed. A total of 347 participants provided demographic data information. Responses revealed variations in diagnostic practice and subsequent management. Participants believed that the acceptable rate for nondiagnostic samples should not be higher than 10%. There were varied opinions regarding the approach to neoplastic lesions of uncertain malignant potential, those that may or may have not local invasion and distant spread.
Results of the survey demonstrated strong support for the development of a unified system for reporting SGC. Cancer Cytopathol 2017;125:757-66. © 2017 American Cancer Society.
在美国细胞病理学学会(ASC)和国际细胞学会的支持下,一个涎腺细胞学(SGC)领域的国际专家小组开展了一项调查,以探寻有关SGC的证据和实践模式。研究结果被用于为拟议的《米兰涎腺细胞病理学报告系统》提供重点依据。
该研究小组在2015年于意大利米兰举行的欧洲细胞学会大会期间组建,编制了一项包含49个与涎腺细胞学的分类法、实践及诊断实体相关的具体问题的调查问卷。使用Qualtrics软件作为研究平台。由威斯康星大学信息技术部门提供软件和服务器支持。该调查于2015年11月至2016年2月在线提供。通过ASC、国际细胞学会和帕潘icolaou细胞病理学学会的网站以及ASC电子邮件“ListServe”邀请参与者;由《米兰系统》编辑评估回复。
共收集并审查了515名参与者的回复。共有347名参与者提供了人口统计学数据信息。回复揭示了诊断实践和后续管理方面的差异。参与者认为非诊断性样本的可接受率不应高于10%。对于具有不确定恶性潜能的肿瘤性病变,即那些可能有或可能没有局部侵袭和远处转移的病变,存在不同的观点。
调查结果表明强烈支持开发一个统一的SGC报告系统。《癌症细胞病理学》2017;125:757 - 66。©2017美国癌症协会。